People with rare harmful changes in the SRSF2 gene tend to die earlier — about 5.8 times more likely — than those without it, and this might be because of a blood condition that can lead to leukemia.

The study found that people with certain rare genetic changes in the SRSF2 gene tend to live shorter lives, and this may be linked to blood conditions that can lead to cancer, which matches the main idea of the claim.